MVA-BN-HER2

BIOLOGICAL2 trials

Sponsors

Bavarian Nordic

Conditions

Breast Cancer

Phase 1

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer

CompletedNCT00485277

Bavarian NordicBreast Cancer

Start: 2007-06-30End: 2010-09-30Updated: 2019-03-14

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy

CompletedNCT01152398

Bavarian NordicBreast Cancer

Start: 2010-06-30End: 2012-09-30Updated: 2019-03-14